SoftBank Group has taken control of Arm, the chip designer, in a deal worth $64 billion. SoftBank now owns 95% in the company, with its Vision Fund unit indirectly owning the remaining 25%. This news came after SoftBank took Arm Ltd. private for $32 billion in 2016.
SoftBank will retain a stake of as much as 90 percent in the company and is expected to sell fewer Arm shares in the initial public offering (IPO) that is scheduled for September. Talks are underway to list Arm at a valuation of between $60 billion to $70 billion.
Read more: Softbank’s Fortress Considers $6.8B Takeover Of UK’s Motor Fuel Group
Anirban Sen from Reuters commented on the deal “SoftBank Group has acquired the 25% stake in Arm Ltd it does not directly own from its Vision Fund unit in a deal that values the chip designer at $64 billion.”
Arm is a semiconductor and software design company best known for its reduction of energy used in the manufacturing of semiconductor chips. It specializes in designing processor architectures and cores, CPUs, GPUs, and software platforms used in various devices, including Apple and Android devices.
This news implies that SoftBank Group may be preparing for an IPO of Arm Ltd. Details are expected to be finalized in September when the IPO becomes available to the public.
Source: Reuters
Featured News
European Music Streaming Firms Rally Against Apple’s Proposed Remedies
May 9, 2024 by
CPI
Google and South Carolina Clash Over State Records Demand
May 8, 2024 by
CPI
Telefonica Germany Teams Up with Amazon Web Services to Migrate 5G Customers
May 8, 2024 by
CPI
Federal Judge Grants $7.4 Million Settlement in Pork Price-Fixing Case
May 8, 2024 by
CPI
Wilson Sonsini Bolsters Antitrust and Competition Practice with Key Partner Returns
May 8, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Economics of Criminal Antitrust
Apr 19, 2024 by
CPI
Navigating Economic Expert Work in Criminal Antitrust Litigation
Apr 19, 2024 by
CPI
The Increased Importance of Economics in Cartel Cases
Apr 19, 2024 by
CPI
A Law and Economics Analysis of the Antitrust Treatment of Physician Collective Price Agreements
Apr 19, 2024 by
CPI
Information Exchange In Criminal Antitrust Cases: How Economic Testimony Can Tip The Scales
Apr 19, 2024 by
CPI